http://opendata.unex.es/recurso/educacion/universidad/personal/b49433806ef6a413d3da88fdd06a1690-nelson-rodolfo-lopez-sejas
Relations
- ou:tienePublicacion
- Characterization of the dnam-1, tigit and tactile axis on circulating nk, nkt-like and t cell subsets in patients with acute myeloid leukemia
- Current progress in NK cell biology and NK cell-based cancer immunotherapy
- DNAM-1 and the TIGIT/PVRIG/TACTILE axis: Novel immune checkpoints for natural killer cell-based cancer immunotherapy
- Differential effect of cytomegalovirus infection with age on the expression of CD57, CD300a, and CD161 on T-Cell subpopulations
- Effect of Age on NK Cell Compartment in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors
- Effect of CMV and aging on the differential expression of CD300a, CD161, T-bet, and eomes on NK cell subsets
- Effect of age and latent CMV infection on CD8+ CD56+ T cells (NKT-like) frequency and functionality
- Effect of cytomegalovirus (CMV) and ageing on T-bet and Eomes expression on T-cell subsets
- Enhanced expression of natural cytotoxicity receptors on cytokine-induced memory-like natural killer cells correlates with effector function
- Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age
- Immunosenescence: Implications for response to infection and vaccination in older people
- Immunosenescence: limitations of natural killer cell-based cancer immunotherapy
- Impact of Cytomegalovirus and Age on T-Cell Subsets Defined by CD161, CD300a, and/or CD57 Expression in Healthy Andalusians
- Modulation of NK cells with checkpoint inhibitors in the context of cancer immunotherapy
- Nkt-like (Cd3+cd56+) cells in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
- ou:perteneceAGrupoInvestigacion
